Cargando…

Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING

BACKGROUND: Localized radiotherapy (RT) can cause a T cell-mediated abscopal effect on non-irradiated tumor lesions, especially in combination with immune checkpoint blockade. However, this effect is still clinically rare and improvements are highly desirable. We investigated whether triple combinat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Liqun, Luo, Ren, Onyshchenko, Kateryna, Rao, Xi, Wang, Meidan, Menz, Beatrice, Gaedicke, Simone, Grosu, Anca-Ligia, Firat, Elke, Niedermann, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462948/
https://www.ncbi.nlm.nih.gov/pubmed/37640480
http://dx.doi.org/10.1136/jitc-2022-006235
_version_ 1785098145713094656
author Wang, Liqun
Luo, Ren
Onyshchenko, Kateryna
Rao, Xi
Wang, Meidan
Menz, Beatrice
Gaedicke, Simone
Grosu, Anca-Ligia
Firat, Elke
Niedermann, Gabriele
author_facet Wang, Liqun
Luo, Ren
Onyshchenko, Kateryna
Rao, Xi
Wang, Meidan
Menz, Beatrice
Gaedicke, Simone
Grosu, Anca-Ligia
Firat, Elke
Niedermann, Gabriele
author_sort Wang, Liqun
collection PubMed
description BACKGROUND: Localized radiotherapy (RT) can cause a T cell-mediated abscopal effect on non-irradiated tumor lesions, especially in combination with immune checkpoint blockade. However, this effect is still clinically rare and improvements are highly desirable. We investigated whether triple combination with a low dose of clinically approved liposomal doxorubicin (Doxil) could augment abscopal responses compared with RT/αPD-1 and Doxil/αPD-1. We also investigated whether the enhanced abscopal responses depended on the mitochondrial DNA (mtDNA)/cyclic GMP-AMP synthase (cGAS)/stimulator of interferon genes (STING)/IFN-I pathway. MATERIALS/METHODS: We used Doxil in combination with RT and αPD-1 in two tumor models (B16-CD133 melanoma and MC38 colon carcinoma) with mice bearing two tumors, only one of which was irradiated. Mechanistic studies on the role of the mtDNA/cGAS/STING/IFN-I axis were performed using inhibitors and knockout cells in vitro as well as in mice. RESULTS: Addition of a single low dose of Doxil to RT and αPD-1 strongly enhanced the RT/αPD-1-induced abscopal effect in both models. Complete cures of non-irradiated tumors were mainly observed in triple-treated mice. Triple therapy induced more cross-presenting dendritic cells (DCs) and more tumor-specific CD8(+) T cells than RT/αPD-1 and Doxil/αPD-1, particularly in non-irradiated tumors. Coincubation of Doxil-treated and/or RT-treated tumor cells with DCs enhanced DC antigen cross-presentation which is crucial for inducing CD8(+) T cells. CD8(+) T cell depletion or implantation of cGAS-deficient or STING-deficient tumor cells abolished the abscopal effect. Doxorubicin-induced/Doxil-induced IFNβ1 markedly depended on the cGAS/STING pathway. Doxorubicin-treated/Doxil-treated tumor cells depleted of mtDNA secreted less IFNβ1, of the related T cell-recruiting chemokine CXCL10, and ATP; coincubation with mtDNA-depleted tumor cells strongly reduced IFNβ1 secretion by DCs. Implantation of mtDNA-depleted tumor cells, particularly at the non-irradiated/abscopal site, substantially diminished the Doxil-enhanced abscopal effect and tumor infiltration by tumor-specific CD8(+) T cells. CONCLUSIONS: These data show that single low-dose Doxil can substantially enhance the RT/αPD-1-induced abscopal effect, with a strong increase in cross-presenting DCs and CD8(+) tumor-specific T cells particularly in abscopal tumors compared with RT/αPD-1 and Doxil/αPD-1. Moreover, they indicate that the mtDNA/cGAS/STING/IFN-I axis is important for the immunogenic/immunomodulatory doxorubicin effects. Our findings may be helpful for the planning of clinical radiochemoimmunotherapy trials in (oligo)metastatic patients.
format Online
Article
Text
id pubmed-10462948
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-104629482023-08-30 Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING Wang, Liqun Luo, Ren Onyshchenko, Kateryna Rao, Xi Wang, Meidan Menz, Beatrice Gaedicke, Simone Grosu, Anca-Ligia Firat, Elke Niedermann, Gabriele J Immunother Cancer Clinical/Translational Cancer Immunotherapy BACKGROUND: Localized radiotherapy (RT) can cause a T cell-mediated abscopal effect on non-irradiated tumor lesions, especially in combination with immune checkpoint blockade. However, this effect is still clinically rare and improvements are highly desirable. We investigated whether triple combination with a low dose of clinically approved liposomal doxorubicin (Doxil) could augment abscopal responses compared with RT/αPD-1 and Doxil/αPD-1. We also investigated whether the enhanced abscopal responses depended on the mitochondrial DNA (mtDNA)/cyclic GMP-AMP synthase (cGAS)/stimulator of interferon genes (STING)/IFN-I pathway. MATERIALS/METHODS: We used Doxil in combination with RT and αPD-1 in two tumor models (B16-CD133 melanoma and MC38 colon carcinoma) with mice bearing two tumors, only one of which was irradiated. Mechanistic studies on the role of the mtDNA/cGAS/STING/IFN-I axis were performed using inhibitors and knockout cells in vitro as well as in mice. RESULTS: Addition of a single low dose of Doxil to RT and αPD-1 strongly enhanced the RT/αPD-1-induced abscopal effect in both models. Complete cures of non-irradiated tumors were mainly observed in triple-treated mice. Triple therapy induced more cross-presenting dendritic cells (DCs) and more tumor-specific CD8(+) T cells than RT/αPD-1 and Doxil/αPD-1, particularly in non-irradiated tumors. Coincubation of Doxil-treated and/or RT-treated tumor cells with DCs enhanced DC antigen cross-presentation which is crucial for inducing CD8(+) T cells. CD8(+) T cell depletion or implantation of cGAS-deficient or STING-deficient tumor cells abolished the abscopal effect. Doxorubicin-induced/Doxil-induced IFNβ1 markedly depended on the cGAS/STING pathway. Doxorubicin-treated/Doxil-treated tumor cells depleted of mtDNA secreted less IFNβ1, of the related T cell-recruiting chemokine CXCL10, and ATP; coincubation with mtDNA-depleted tumor cells strongly reduced IFNβ1 secretion by DCs. Implantation of mtDNA-depleted tumor cells, particularly at the non-irradiated/abscopal site, substantially diminished the Doxil-enhanced abscopal effect and tumor infiltration by tumor-specific CD8(+) T cells. CONCLUSIONS: These data show that single low-dose Doxil can substantially enhance the RT/αPD-1-induced abscopal effect, with a strong increase in cross-presenting DCs and CD8(+) tumor-specific T cells particularly in abscopal tumors compared with RT/αPD-1 and Doxil/αPD-1. Moreover, they indicate that the mtDNA/cGAS/STING/IFN-I axis is important for the immunogenic/immunomodulatory doxorubicin effects. Our findings may be helpful for the planning of clinical radiochemoimmunotherapy trials in (oligo)metastatic patients. BMJ Publishing Group 2023-08-28 /pmc/articles/PMC10462948/ /pubmed/37640480 http://dx.doi.org/10.1136/jitc-2022-006235 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Clinical/Translational Cancer Immunotherapy
Wang, Liqun
Luo, Ren
Onyshchenko, Kateryna
Rao, Xi
Wang, Meidan
Menz, Beatrice
Gaedicke, Simone
Grosu, Anca-Ligia
Firat, Elke
Niedermann, Gabriele
Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING
title Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING
title_full Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING
title_fullStr Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING
title_full_unstemmed Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING
title_short Adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αPD1 therapy depending on tumor cell mitochondrial DNA and cGAS/STING
title_sort adding liposomal doxorubicin enhances the abscopal effect induced by radiation/αpd1 therapy depending on tumor cell mitochondrial dna and cgas/sting
topic Clinical/Translational Cancer Immunotherapy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462948/
https://www.ncbi.nlm.nih.gov/pubmed/37640480
http://dx.doi.org/10.1136/jitc-2022-006235
work_keys_str_mv AT wangliqun addingliposomaldoxorubicinenhancestheabscopaleffectinducedbyradiationapd1therapydependingontumorcellmitochondrialdnaandcgassting
AT luoren addingliposomaldoxorubicinenhancestheabscopaleffectinducedbyradiationapd1therapydependingontumorcellmitochondrialdnaandcgassting
AT onyshchenkokateryna addingliposomaldoxorubicinenhancestheabscopaleffectinducedbyradiationapd1therapydependingontumorcellmitochondrialdnaandcgassting
AT raoxi addingliposomaldoxorubicinenhancestheabscopaleffectinducedbyradiationapd1therapydependingontumorcellmitochondrialdnaandcgassting
AT wangmeidan addingliposomaldoxorubicinenhancestheabscopaleffectinducedbyradiationapd1therapydependingontumorcellmitochondrialdnaandcgassting
AT menzbeatrice addingliposomaldoxorubicinenhancestheabscopaleffectinducedbyradiationapd1therapydependingontumorcellmitochondrialdnaandcgassting
AT gaedickesimone addingliposomaldoxorubicinenhancestheabscopaleffectinducedbyradiationapd1therapydependingontumorcellmitochondrialdnaandcgassting
AT grosuancaligia addingliposomaldoxorubicinenhancestheabscopaleffectinducedbyradiationapd1therapydependingontumorcellmitochondrialdnaandcgassting
AT firatelke addingliposomaldoxorubicinenhancestheabscopaleffectinducedbyradiationapd1therapydependingontumorcellmitochondrialdnaandcgassting
AT niedermanngabriele addingliposomaldoxorubicinenhancestheabscopaleffectinducedbyradiationapd1therapydependingontumorcellmitochondrialdnaandcgassting